J. MITRA & CO PRIVATE LIMITED

New Delhi-based J. Mitra & Co. generated a revenue of Rs 84.8 crore during FY 20-21, showing a decline of 36 per cent in its business, when compared to the revenue generation of Rs 133 crore in the previous year. During 2020, the company launched its state-of-theart COVID-19 test kit in the Indian market, based on the double sandwich Elisa technology. It is a serology-based total antibody (IgM, IgG, IgA) detection assay. The company deployed extensive indigenous R&D for the development of this unique product with substantial contribution in its development by New Delhi-based International Centre for Genetic Engineering & Biotechnology (ICGEB).